Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Research Article, Androl Gynecol Curr Res Vol: 2 Issue: 3
Aromatase Inhibitor for Prevention of Ovarian Hyperstimulation Syndrome(OHSS)
| Mosammat Rashida Begum*, Mariya Ehsan, Mosammat Shahina Begum, Hosne Ara Beby, and Maruf Siddiqui |
| Infertility Care and Research Center (ICRC), Dhaka, Bangladesh |
| Corresponding author : Prof. Mosammat Rashida Begum Chief Consultant, Infertility Care and Research Center (ICRC), 5/13 Humaun Road, Block “B”, Mohammadpur, Dhaka 1207, Bangladesh E-mail: rashida_icrc@yahoo.com |
| Received: March 14, 2014 Accepted: May 13, 2014 Published: May 17, 2014 |
| Citation: Ehsan M, Begum MS, Beby HA, Siddiqui M, Begum MR (2014) Aromatase Inhibitor for Prevention of Ovarian Hyperstimulation Syndrome (OHSS). Androl Gynecol: Curr Res 2:3. doi: 10.4172/2327-4360.1000125 |
Abstract
Aromatase Inhibitor for Prevention of Ovarian Hyperstimulation Syndrome(OHSS)
Ovarian hyperstimulation syndrome (OHSS) was first described by Muller in 1962. Since then this iatrogenically originated malady has been reported to afflict high numbers of women who are in infertility treatment. The most serious and potentially lethal complication of controlled ovarian hyperstimulation (COH) is a severe form of OHSS. The incidence of OHSS is 5%-10% of all ovarian hyperstimulation for assisted reproduction treatment. It is characterized by ovarian enlargement with multiple follicular development, intravascular volume depletion and haemoconcentration.
